Side-by-side comparison of AI visibility scores, market position, and capabilities
Haleon (HLN) world's #1 sensitive teeth toothpaste in 130+ countries; $2B+ revenue with clinical desensitizing formulas and dentist-recommended positioning competing with Colgate Sensitive.
Sensodyne is the world's #1 dentist-recommended toothpaste brand for sensitive teeth — owned by Haleon plc (LSE/NYSE: HLN), the consumer healthcare company spun out of GlaxoSmithKline in 2022. Sensodyne's clinically proven formulations (potassium nitrate or stannous fluoride as active desensitizing ingredients) treat and prevent tooth sensitivity while providing cavity protection, enamel strengthening, and whitening benefits. Available in 130+ countries and generating approximately $2+ billion in annual retail sales, Sensodyne is Haleon's largest brand and one of the world's most profitable consumer healthcare products.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.